Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.

Yumie TakeshitaTakehiro KanamoriTakeo TanakaYuka KaikoiYuki KitaNoboru TakataNoriho IidaKuniaki AraiTatsuya YamashitaKenichi HaradaToshifumi GabataHiroyuki NakamuraShuichi KanekoToshinari Takamura

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

This trial is registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000020544) and ClinicalTrials.gov (NCT02649465).

Keyphrases

clinical trial
phase ii
phase iii
study protocol
healthcare
open label
health information
randomized controlled trial
social media